| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1011223092 |
| P356 | DOI | 10.1111/J.0022-202X.2004.23546.X |
| P932 | PMC publication ID | 1613794 |
| P698 | PubMed publication ID | 15675948 |
| P50 | author | Gary Burkholder | Q46354607 |
| P2093 | author name string | Raymond G Dufresne | |
| Bruce K Armstrong | |||
| Melody J Eide | |||
| Katharine A Phillips | |||
| Leslie Robinson-Bostom | |||
| Martin A Weinstock | |||
| Patricia Risica | |||
| David Upegui | |||
| Suleka Neelagaru | |||
| P2860 | cites work | Clinical measurement of dimensions of basal cell carcinoma: effect of waiting for elective surgery | Q33785605 |
| The period prevalence and costs of treating nonmelanoma skin cancers in patients over 65 years of age covered by medicare | Q34459168 | ||
| Mohs' micrographic surgery for treatment of basal cell carcinoma of the face--results of a retrospective study and review of the literature | Q35843831 | ||
| Cutaneous malignant melanoma: audit of the diagnostic process | Q36816867 | ||
| Biology of basal cell carcinoma (Part I). | Q37648649 | ||
| Why patients delay seeking care for cancer symptoms. What you can do about it. | Q37651401 | ||
| Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up | Q38606362 | ||
| Reliability of counting actinic keratoses before and after brief consensus discussion: the VA topical tretinoin chemoprevention (VATTC) trial | Q40683136 | ||
| Delays in diagnosis and melanoma prognosis (I): the role of patients | Q40760215 | ||
| Basal cell carcinoma. Identification and treatment of the high-risk patient | Q40969359 | ||
| Delay in the diagnosis of cutaneous malignant melanoma. A prospective study in 250 patients | Q41138914 | ||
| Recurrence rates of treated basal cell carcinomas. Part 1: Overview | Q42472213 | ||
| Predictors of extensive subclinical spread in nonmelanoma skin cancer treated with Mohs micrographic surgery | Q42524538 | ||
| Cancer statistics, 2003. | Q43729872 | ||
| Prognostic and psychosocial factors related to delay behavior in patients with cutaneous malignant melanoma | Q46668120 | ||
| A Community Study of Delay in Presenting With Signs of Melanoma to Medical Practitioners | Q56749840 | ||
| Patient Knowledge, Awareness, and Delay in Seeking Medical Attention for Malignant Melanoma | Q59626604 | ||
| Delays in diagnosis and melanoma prognosis (II): The role of doctors | Q61908779 | ||
| Melanoma and Tumor Thickness | Q61908810 | ||
| Patient and physician delay in melanoma diagnosis | Q68291963 | ||
| Patients' and doctors' delay in the diagnosis and treatment of cutaneous melanoma | Q69580196 | ||
| Correlation of thicknesses of superficial spreading malignant melanomas and ages of patients | Q70798462 | ||
| Dimensions of Hypochondriasis | Q72230856 | ||
| Awareness and early detection of cutaneous melanoma: an analysis of factors related to delay in treatment | Q73230859 | ||
| Clinical correlates of Breslow thickness of malignant melanoma | Q73646363 | ||
| Surgical margins for excision of primary cutaneous melanoma | Q73727146 | ||
| Time delays and related factors in the diagnosis of cutaneous melanoma | Q73784667 | ||
| The time from diagnostic excision biopsy to wide local excision for primary cutaneous malignant melanoma may not affect patient survival | Q74418281 | ||
| Delay in the diagnosis of cutaneous melanoma: an analysis of 233 patients | Q74594083 | ||
| Thickness and delay in diagnosis of melanoma: how far can we go? | Q74623418 | ||
| Role of physicians and patients in the diagnostic delay of cutaneous malignant melanoma | Q78347503 | ||
| The relationship of psychosocial factors to prognostic indicators in cutaneous malignant melanoma | Q93577815 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | keratinocyte | Q1473931 |
| P304 | page(s) | 308-314 | |
| P577 | publication date | 2005-02-01 | |
| P1433 | published in | Journal of Investigative Dermatology | Q3186921 |
| P1476 | title | Relationship of treatment delay with surgical defect size from keratinocyte carcinoma (basal cell carcinoma and squamous cell carcinoma of the skin). | |
| P478 | volume | 124 |
| Q42504065 | Basal cell carcinoma growth in patients waiting for Mohs surgery: a prospective study |
| Q42499738 | Dermoscopy of small-size basal cell carcinoma: a case-control study. |
| Q37644602 | Initial basal cell carcinomas diagnosed in the National Campaign for Skin Cancer Prevention are smaller than those identified by the conventional medical referral system |
| Q38731383 | Is early detection of basal cell carcinoma worthwhile? Systematic review based on the WHO criteria for screening |
| Q96029667 | Management of primary skin cancer during a pandemic: Multidisciplinary recommendations |
| Q36736823 | Melanoma early detection with thorough skin self-examination: the "Check It Out" randomized trial |
| Q37415672 | Patient Factors and Their Association with Nonmelanoma Skin Cancer Morbidity and the Performance of Self-skin Exams: A Cross-Sectional Study |
| Q89588153 | Treatment of keratinocyte carcinoma in elderly patients - a review of the current literature |
| Q79949501 | [Analysis of surgical treatment for nonmelanoma skin cancer performed by dermatologists in a public hospital: clinical-pathological correlation, use of hospital resources, and waiting list time from diagnosis] |
Search more.